QQ客服 官方微博 反馈留言

	Decitabine for Treatment of Myelodysplastic Syndromes in Chinese Patients: An Open-Label, Phase-3b Study
	Wu, Depei; Du, Xin; Jin, Jie; Xiao, Zhijian; Shen, Zhixiang; Shao, Zonghong; Li, Xiao; Huang, Xiaojun; Liu, Ting; Yu, Li
	2015
卷号	32期号:11页码:1140-1159
关键词	Chinese population Decitabine Hematology Myelodysplastic syndrome (MDS) Oncology Phase 3b
ISSN号	0741-238X
DOI	10.1007/s12325-015-0263-8
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6663666
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Wu, Depei,Du, Xin,Jin, Jie,et al. Decitabine for Treatment of Myelodysplastic Syndromes in Chinese Patients: An Open-Label, Phase-3b Study[J],2015,32(11):1140-1159.
APA	Wu, Depei.,Du, Xin.,Jin, Jie.,Xiao, Zhijian.,Shen, Zhixiang.,...&Ruan, Changgeng.(2015).Decitabine for Treatment of Myelodysplastic Syndromes in Chinese Patients: An Open-Label, Phase-3b Study.,32(11),1140-1159.
MLA	Wu, Depei,et al."Decitabine for Treatment of Myelodysplastic Syndromes in Chinese Patients: An Open-Label, Phase-3b Study".32.11(2015):1140-1159.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。